Ersbøll AK, Sengupta K, Pukkala E, Bolin K, Aas E, Emneus M, Ramey DR, Brady JE, Mines D, Aasbjerg K, Vestergaard C, Gislason G, Born AP, Kjærulff TM. Desloratadine exposure and incidence of seizure: a nordic post-authorization safety study using a new-user cohort study design, 2001-2015. Drug Saf. 2021 Nov;44(11):1231-42. doi: 10.1007/s40264-021-01106-7
Wang FT, Green E, Mines D, Mehta V, Lin ND. A study to assess the capture of sublingual immunotherapy within an electronic health record (EHR) system. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2018. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 25(S3):395-6.
Wang T, Liu Z, Mines D. Adding of CPT codes improves classification of type of bowel resection based only on ICD-9-CM procedure codes. Poster presented at the 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2018. Dublin, Ireland. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 25(S3):162.
Fortuny J, Rasouliyan L, Mines D, Tormos A, Earley E, Perez-Gutthann S, Domenech E, Gisbert JP. Characterization of patients with ulcerative colitis in a post-authorization safety study of golimumab based in the Spanish ENEIDA Registry. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):47. doi: 10.1002/pds.4629